Patents by Inventor Stephen Redenti

Stephen Redenti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9801844
    Abstract: The invention provides compositions with low toxicity and high bioavailability for treating cancer or for inhibiting the development of cancer.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: October 31, 2017
    Assignee: The Research Foundation of the City University of New York
    Inventors: Linda S. Einbond, Stephen Redenti
  • Publication number: 20140234381
    Abstract: The following disclosure provides compositions and methods for the repairing of a diseased or disordered retina, for example, in patients suffering from age-related macular degeneration (AMD).
    Type: Application
    Filed: December 23, 2013
    Publication date: August 21, 2014
    Applicants: The Charles Stark Draper Laboratory, Inc., The Schepens Eye Research Institute, Inc.
    Inventors: Sarah L. Tao, Stephen Redenti, Magali Saint-Geniez, Michael Young, Patricia D'Amore
  • Publication number: 20130315983
    Abstract: The invention provides compositions with low toxicity and high bioavailability for treating cancer or for inhibiting the development of cancer
    Type: Application
    Filed: May 24, 2013
    Publication date: November 28, 2013
    Applicant: The Research Foundation of the City University of New York
    Inventors: Linda S. Einbond, Stephen Redenti
  • Publication number: 20110004304
    Abstract: Disclosed are various methods and bioreactor devices for culturing retinal cells and/or tissues. The bioreactor devices may, in certain embodiments, include a microchannel network, a scaffold for culturing neuroretinal cells, and a porous membrane separating the microchannel network from the scaffold.
    Type: Application
    Filed: March 19, 2010
    Publication date: January 6, 2011
    Inventors: Sarah L. Tao, Stephen Redenti, Sonal Sodha, Jeffrey T. Borenstein, Michael Young